These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 2988926)
1. Pressor-type vasopressin receptors in the adrenal cortex: properties of binding, effects on phosphoinositide metabolism and aldosterone secretion. Balla T; Enyedi P; Spät A; Antoni FA Endocrinology; 1985 Jul; 117(1):421-3. PubMed ID: 2988926 [TBL] [Abstract][Full Text] [Related]
2. Involvement of protein kinase C in the coupling between the V1 vasopressin receptor and phospholipase C in rat glomerulosa cells: effects on aldosterone secretion. Gallo-Payet N; Chouinard L; Balestre MN; Guillon G Endocrinology; 1991 Aug; 129(2):623-34. PubMed ID: 1830269 [TBL] [Abstract][Full Text] [Related]
3. Vasopressin stimulates phosphatidylinositol turnover and aldosterone synthesis in rat adrenal glomerulosa cells: comparison with angiotensin II. Woodcock EA; Mcleod JK; Johnston CI Endocrinology; 1986 Jun; 118(6):2432-6. PubMed ID: 2938936 [TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of arginine vasopressin receptors in the rat testis. Meidan R; Hsueh AJ Endocrinology; 1985 Jan; 116(1):416-23. PubMed ID: 2981073 [TBL] [Abstract][Full Text] [Related]
5. Interaction of a vasopressin antagonist with vasopressin receptors in the septum of the rat brain. Dorsa DM; Brot MD; Shewey LM; Meyers KM; Szot P; Miller MA Synapse; 1988; 2(3):205-11. PubMed ID: 2975069 [TBL] [Abstract][Full Text] [Related]
6. Influence of sodium and potassium diets on adrenal vasopressin content and direct effects of vasopressin on aldosterone synthesis in adrenocortical cells. Bähr V; Sander-Bähr C; Hensen J; Oelkers W Horm Metab Res; 1993 Aug; 25(8):411-6. PubMed ID: 8225184 [TBL] [Abstract][Full Text] [Related]
7. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor. Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327 [TBL] [Abstract][Full Text] [Related]
8. In-vitro and in-vivo studies of the effects of arginine-vasopressin on the secretion and growth of rat adrenal cortex. Mazzochi G; Malendowicz LK; Meneghelli V; Gottardo G; Nussdorfer GG Histol Histopathol; 1995 Apr; 10(2):359-70. PubMed ID: 7599433 [TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin II and arginine vasopressin on aldosterone production and phosphoinositide turnover in rat adrenal glomerulosa cells: a comparative study. Enyedi P; Balla T; Antoni FA; Spät A J Mol Endocrinol; 1988 Sep; 1(2):117-24. PubMed ID: 2855590 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of vasotocin stimulation of phosphoinositide turnover in frog adrenal gland. Larcher A; Delarue C; Homo-Delarche F; Kikuyama S; Kupryszewski G; Vaudry H Endocrinology; 1992 Jan; 130(1):475-83. PubMed ID: 1309345 [TBL] [Abstract][Full Text] [Related]
12. V1-type vasopressin receptors in rat brain septum: binding characteristics and effects on inositol phospholipid metabolism. Shewey LM; Dorsa DM J Neurosci; 1988 May; 8(5):1671-7. PubMed ID: 2835449 [TBL] [Abstract][Full Text] [Related]
13. Vasopressin (V1) receptor characteristics in rat aortic smooth muscle cells. Gopalakrishnan V; Xu YJ; Sulakhe PV; Triggle CR; McNeill JR Am J Physiol; 1991 Dec; 261(6 Pt 2):H1927-36. PubMed ID: 1836312 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological evaluation of d(CH2)5Tyr(Me)AVP as an antagonist of vasopressin-induced contraction of the isolated rat caudal artery. Clineschmidt BV; Lis EV Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):72-84. PubMed ID: 2950833 [TBL] [Abstract][Full Text] [Related]
15. Vascular vasopressin receptors mediate phosphatidylinositol turnover and calcium efflux in an established smooth muscle cell line. Aiyar N; Nambi P; Stassen FL; Crooke ST Life Sci; 1986 Jul; 39(1):37-45. PubMed ID: 3014249 [TBL] [Abstract][Full Text] [Related]
16. Distinct mechanisms of action of V1 antagonists OPC-21268 and [d(CH2)5Tyr(Me)AVP] in mesangial cells. Jamil KM; Watanabe T; Nakao A; Okuda T; Kurokawa K Biochem Biophys Res Commun; 1993 Jun; 193(2):738-43. PubMed ID: 8390252 [TBL] [Abstract][Full Text] [Related]
17. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin. Hinojosa C; Haywood JR J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211 [TBL] [Abstract][Full Text] [Related]
18. Vasopressin-stimulated phosphoinositide hydrolysis in cultured rat inner medullary collecting duct cells is mediated by the oxytocin receptor. Teitelbaum I J Clin Invest; 1991 Jun; 87(6):2122-6. PubMed ID: 1645753 [TBL] [Abstract][Full Text] [Related]
19. [3H]AVP binding to rat renal tubular receptors during long-term treatment with an antagonist of arginine vasopressin. Mah SC; Whitebread SE; De Gasparo M; Hofbauer KG Peptides; 1988; 9(3):595-600. PubMed ID: 3420014 [TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of vascular (V1) vasopressin receptors of an established smooth muscle cell line. Stassen FL; Heckman G; Schmidt D; Aiyar N; Nambi P; Crooke ST Mol Pharmacol; 1987 Mar; 31(3):259-66. PubMed ID: 2951584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]